3billion, Inc. (KOSDAQ:394800)
13,190
-720 (-5.18%)
At close: Feb 6, 2026
3billion Revenue
3billion had revenue of 3.23B KRW in the quarter ending September 30, 2025, with 150.43% growth. This brings the company's revenue in the last twelve months to 9.78B, up 102.61% year-over-year. In the year 2024, 3billion had annual revenue of 5.77B with 111.41% growth.
Revenue (ttm)
9.78B
Revenue Growth
+102.61%
P/S Ratio
42.82
Revenue / Employee
n/a
Employees
n/a
Market Cap
418.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.77B | 3.04B | 111.41% |
| Dec 31, 2023 | 2.73B | 1.90B | 229.57% |
| Dec 31, 2022 | 828.46M | 277.80M | 50.45% |
| Dec 31, 2021 | 550.66M | 525.57M | 2,095.26% |
| Dec 31, 2020 | 25.08M | -5.18M | -17.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Cross Medical Science | 111.12B |
| Seoulin Bioscience | 76.74B |
| Dx & Vx | 29.47B |
| Cytogen | 25.09B |
| HLB Panagene | 14.29B |
| Protia | 13.52B |
| GENINUS | 8.81B |
| Median Diagnostics | 7.86B |